RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
1332. Sacco RL, Benjamin EJ, Broderick JP , Howard G, Kittner SJ,
Manolio TA y cols. American Heart Association Prevention
Conference. Prevention and Rehabilitation of stroke. Risk
factors stroke 28:1507-17, 1997.
1333. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL,
Wolfson SK Jr. Carotid-artery intima and media thickness as
a risk factor for myocardial infarction and stroke in older
adults. Cardiovascular Health Study Collaborative Research
Group. N Engl J Med 340:14-22, 1999.
1334. Amarenco P,Cohen A, Tzourion C Bertrand B, Hommel M,
Besson G, y cols. Atherosclerotic disease of the aortic arch
and the risk of ischemic stroke. N Engl J Med 331:1474-9,
1994.
1335. Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K, Nishime K
y cols. Evidence for high risk of cerebral hemorrhage in
chronic dialysis patients. Kidney Int 44:1086-1090, 1993.
1336. Onoyama K, Kumagai H, Miishima T, Tsuruda H, Tomooka S,
Motomura K y cols. Incidence of strokes and its prognosis in
patients on maintenance hemodialysis. Jpn Heart J 27:685-
691, 1986.
1337. Nakatani T, Naganuma T, Uchida J, Masuda C, Wada S,
Sugimura T, y cols. Silent cerebral infarction in hemodialysis
patients. Am J Nephrol 23:86-90, 2003.
1338. Fisher CM. Lacunar strokes and infarcts: A review. Neurology
32:871-876, 1982.
1339. Howard G, Wagenknecht LE, Cai J, Cooper L, Kaut MA,
Toole JF.Cigarette smoking and other risks factor for silent
cerebral infarction in the general population. Stroke 29:913-
917, 1998.
1340. Furie K. Stroke prevention. N Engl J Med 346:213-214, 2001.
1341. Mc Mahon S, Rodgers A. Blood pressure, antihypertensive
treatment and stroke risk. J Hypertens 12(supl 10): S5-S14,
1994.
1342. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB,
Hademenos G y cols. Primary prevention of ischemic stroke:
a statement for healthcare professionals fro, the Stroke
Council of the American Heart Association. Circulation
103:163-182, 2001.
1343. Gorelick PB. Stroke prevention therapy beyond antithrombotics:
unifying mechanisms in ischemic stroke pathogenesis
and implication for therapy. Stroke 33:862-875, 2002.
1344. Kannel WB. Blood pressure as a cardiovascular risk factor:
prevention and treatment. JAMA 275:1571-1576, 1996.
1345. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and
diastolic, and cardiovascular risks US population data. Arch
Int Med 153:598-615, 1993.
1346. Seliger SL, Gillern DL, Tirschwell D, Wasse H, Kestenbaum
BR, Stehman-Breen CO. Risk factors for incident stroke
among patients with end-stage renal disease. J Am Soc
Nephrol 14:2623-2631, 2003.
1347. Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB.
Probability of stroke: a risk profile from the Framingham
Study,Stroke 22:312-318, 1991.
1348. Iseki K, Fukiyama K. Predictors of stroke in patients receiving
chronic hemodialysis. Kidney Int 50:1672-1675, 1996.
1349. Gorelick PB. New horizons for stroke prevention: PRO-
GRESS and HOPE. Lancet Neurology 1:149-56, 2002.
1350. Kiyohara Y, Ueda K, Hasuo Y, Fujii I, Yanai T, Wada J y cols.
Hematocrit as a risk factor of cerebral infarction: Long-term
prospective population survey in a Japanese rural community.
Stroke 17:687-692, 1986.
1351. Vedercchia P, Porcellati C,Reboldi G,Gattobigio R, Gorgioni
C, Pearson TA y cols. Left ventricular hypertrophy as an independent
predictor of acute cerebrovascular events in essential
hypertension. Circulation 104:2039-2044, 2001.
1352. Leys D, Deplanque D, Mounier-Vehier C, Mackowiak-
Cordoliani MA, Lucas C, Border R. Stroke prevention:
Management of modifiable risk factors. J Neurol 249:507-
517, 2002.
1353. Combe C,Chauveau P, Laville M, Fouqeu D, Azar R, Cano N
y cols. Influence of nutritional factors and hemodialysis adequacy
on the survival of 1,610 French patients. Am J Kidney
Dis 37;s81-s88, 2001
1354. Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ,
Held PJ, y cols. Mortality risk in hemodialysis patients and
changes in nutritional indicators: DOPPS. Kidney Int
62:2238-2245,2002
1355. Stevinkel . Malnutrition and chronic inflammation as risk
factors for cardiovascular disease in chronic renal failure.
Blood Purif 1 19:143-151, 2001.
1356. Kalantar –ZadehK, Kopple J. Relative contributions of nutrition
and inflammation to clinical outcome in dialysis
patients. Am J Kidney Dis 38:1342-1350, 2001.
1357. Benjamin EF, Wolf PA, D’Agostin RB, Silbershatz H, Kannel
WB,Levey D. Impact of atrial fibrillation on the risk of the
death.The Framinghan Heart Study. Circulation 98:946-952,
1998.
1358. Korzets A, Ory Y, Herman M. Serum potassium levels and
atrial fibrillation in hemodialysis patients. Nephrol Dial
Transplant 16:1090, 2001.
1359. McNamara RL, Tamariz LJ, Segal JB, Bass EB. Management of
atrial fibrillation: review of the evidence for the role of pharmacologic
therapy, electrical cardioversion and echocardiography.
Ann Intern Med 39:1018-1033, 2002.
1360. Heidbüchel H. A paradigm shift in treatment for atrial fibrillation:
from electrical to structural therapy. Eur Heart J
24:2077-2078, 2003.
1361. Pascazio L, Bianco F, Giorgini A, Galli G, Curri G, Panzetta
G. Echo color Doppler imaging of carotid vessels in hemodialysis
patients: evidence of high levels of atheroesclerosis
lesions. Am J Kidney Dis 28:713-20, 1996.
1362. Benedetto FA, Mallamaci F, Tripei G, Zoccali C. Prognostic
value of ultrasonographic measurement of carotid intima
media thickness in dialysis patients. J Am Soc Nephrol 12:
2458-64, 2001.
1363. Maeda N, Sawayama Y, Tatsukawa M, Okada K, Furusyo N,
Shigematsu M y cols. Carotid artery lesions and atherosclerotic
risk factors in Japanese hemodialysis patients.
Atherosclerosis 169:183-192, 2003.
1364. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH.
Hypertension is not adequately controlled in hemodialysis
patients. Am J Kidney Dis 19:453-459, 1992.
1365. Rahman M, Dixit A, Donley V, Gupta S, Hanslik T, Lacson E
y cols. Factors associated with inadequate blood pressure
control in hypertensive hemodialysis patients. Am J Kidney
Dis 33:498-506,1999.
1366. Mailloux LU, Haley WE. Hypertension in the ESRD patient:
Pathophysiology, therapy, outcomes and future directions.
Am J Kidney Dis 32:705-719,1998.
1367. Cruz JM, Piera L, Bragg-Gresham JL, Feldman H, Port FK.
Resultados del estudio internacional de hemodiálisis DOPPS
en Europa y España. Nefrología 23: 437-43, 2003.
228